The Enterprise Value as of November 2024 (TTM) for HUTCHMED (China) Limited (HCM) is 2.91B

According to HUTCHMED (China) Limited’s latest financial reports and current stock price. The company's current Enterprise Value is 2.91B. This represents a change of -80.19% compared to the average of 14.69B of the last 4 quarters.

HUTCHMED (China) Limited (HCM) Historical Enterprise Value (quarterly & annually)

How has HCM Enterprise Value performed in the past?

The mean historical Enterprise Value of HUTCHMED (China) Limited over the last ten years is 14.45B. The current 2.91B Enterprise Value has changed 1.91% with respect to the historical average. Over the past ten years (40 quarters), HCM's Enterprise Value was at its highest in in the September 2021 quarter at 30.90B. The Enterprise Value was at its lowest in in the September 2014 quarter at 0.

HUTCHMED (China) Limited (HCM) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of HUTCHMED (China) Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

HUTCHMED (China) Limited (HCM) Average Enterprise Value

How has HCM Enterprise Value performed in the past?

The current Enterprise Value of HUTCHMED (China) Limited (HCM) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

HUTCHMED (China) Limited (HCM) Enterprise Value vs. Peers

How is HCM’s Enterprise Value compared to its peers?

HUTCHMED (China) Limited’s Enterprise Value is greater than Eagle Pharmaceuticals, Inc. (24.78M), greater than ANI Pharmaceuticals, Inc. (1.68B), greater than Phibro Animal Health Corporation (1.20B), greater than Deciphera Pharmaceuticals, Inc. (2.15B), less than Prestige Consumer Healthcare Inc. (5.20B), greater than Pacira BioSciences, Inc. (1.21B), greater than Collegium Pharmaceutical, Inc. (1.80B), greater than Procaps Group S.A. (376.16M), greater than Silver Spike Investment Corp. (33.56M), less than Alkermes plc (4.63B), less than Intra-Cellular Therapies, Inc. (8.64B), greater than Ironwood Pharmaceuticals, Inc. (677.16M), greater than Regencell Bioscience Holdings Limited (73.51M),

Build a custom stock screener for HUTCHMED (China) Limited (HCM) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like HUTCHMED (China) Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

HUTCHMED (China) Limited (HCM) and other stocks custom spreadsheet templates

The easiest way to analyze a company like HUTCHMED (China) Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.